Oramed Pharmaceuticals, Inc. (ORMP)
5.24
+0.03
(+0.58%)
USD |
NASDAQ |
Aug 26, 13:04
Oramed Pharmaceuticals Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2025 | -382.1% |
| December 31, 2024 | |
| September 30, 2024 | |
| June 30, 2024 | |
| March 31, 2024 | |
| December 31, 2023 | |
| September 30, 2023 | |
| June 30, 2023 | -194.8% |
| March 31, 2023 | -542.2% |
| December 31, 2022 | -1.28K% |
| September 30, 2022 | -1.06K% |
| June 30, 2022 | -1.64K% |
| March 31, 2022 | -1.61K% |
| August 31, 2021 | -1.05K% |
| May 31, 2021 | -826.0% |
| February 28, 2021 | -692.9% |
| November 30, 2020 | -826.4% |
| August 31, 2020 | -439.9% |
| Date | Value |
|---|---|
| May 31, 2020 | -335.4% |
| February 29, 2020 | -547.2% |
| November 30, 2019 | -377.3% |
| August 31, 2019 | -334.8% |
| May 31, 2019 | -597.1% |
| February 28, 2019 | -555.7% |
| November 30, 2018 | -638.3% |
| August 31, 2018 | -474.2% |
| May 31, 2018 | -705.7% |
| February 28, 2018 | -482.8% |
| November 30, 2017 | -414.2% |
| August 31, 2017 | -436.2% |
| May 31, 2017 | -318.5% |
| February 28, 2017 | -520.9% |
| November 30, 2016 | -432.1% |
| August 31, 2016 | -1.35K% |
| May 31, 2016 | -1.22K% |
| February 29, 2016 | -1.45K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Eli Lilly & Co. | 30.88% |
| Pfizer Inc. | -1.64% |
| Yarrow Bioscience, Inc. | -2.99K% |
| Liquidia Corp. | 43.52% |
| NRX Pharmaceuticals, Inc. | -1.50K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 78.30% |
| Return on Assets | 69.54% |
| Return on Invested Capital | 78.02% |
| Return on Net Operating Assets | 13.01K% |